The mission for our company is to provide optical diagnostic information and artificial intelligence for physicians treating patients for Depression and Anxiety
We pride ourselves on being able to assist and protect the medical community. We hope our users are able to see the potential of our product and utilize it to benefit society. We have been granted a US Patent on January 22, 2019, Number: 10,182,755.
The mission for our company is to provide optical diagnostic information and artificial intelligence for physicians treating patients for depression and anxiety. Entering a photo of a patients pupils and iris, in the medical record will help strengthen the patient-physician interaction and help document important side-effects. The company is based on an important medical discovery made by Dr. Ohayon in the pupils of patients taking anti-depressants medication.